JWA
NBIX icon

JFS Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History

JFS Wealth Advisors’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.43K Hold
50
– – ﹤0.01% 1080
2026
Q1 		$6.59K Buy
50
+3
+6% +$398 ﹤0.01% 1101
2025
Q4 		$6.67K Buy
47
+19
+68% +$2.75K ﹤0.01% 1130
2025
Q3 		$3.93K Buy
28
+7
+33% +$948 ﹤0.01% 1212
2025
Q2 		$2.64K Buy
21
+2
+11% +$229 ﹤0.01% 1314
2025
Q1 		$2.1K Sell
19
-20
-51% -$2.53K ﹤0.01% 1450
2024
Q4 		$5.32K Sell
39
-1
-3% -$124 ﹤0.01% 1107
2024
Q3 		$4.61K Buy
40
+11
+38% +$1.51K ﹤0.01% 1151
2024
Q2 		$3.99K Buy
29
+14
+93% +$1.92K ﹤0.01% 1161
2024
Q1 		$2.07K Hold
15
– – ﹤0.01% 1426
2023
Q4 		$1.98K Buy
15
+3
+25% +$345 ﹤0.01% 1445
2023
Q3 		$1.35K Buy
12
+2
+20% +$211 ﹤0.01% 1510
2023
Q2 		$943 Buy
10
+6
+150% +$586 ﹤0.01% 1625
2023
Q1 		$405 Sell
4
-3
-43% -$312 ﹤0.01% 1745
2022
Q4 		$836 Buy
7
+2
+40% +$234 ﹤0.01% 1644
2022
Q3 		$1K Sell
5
-6
-55% -$609 ﹤0.01% 1600
2022
Q2 		$1K Sell
11
-24
-69% -$2.21K ﹤0.01% 1590
2022
Q1 		$3K Buy
35
+23
+192% +$1.95K ﹤0.01% 1281
2021
Q4 		$1K Buy
+12
New +$1.1K ﹤0.01% 1468
2020
Q1 		– Sell
-6
Closed -$1K – 546
2019
Q4 		$1K Hold
6
– – ﹤0.01% 487
2019
Q3 		$1K Buy
+6
New +$561 ﹤0.01% 487

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JFS Wealth Advisors's NBIX Position: Q2 2026 in Review

JFS Wealth Advisors held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 50 shares worth $8.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

JFS Wealth Advisors first reported a position in NBIX in Q3 2019 and has held it in 21 quarters since. 771 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • JFS Wealth Advisors held 50 shares of Neurocrine Biosciences worth $8.43K as of Q2 2026.
  • JFS Wealth Advisors left its Neurocrine Biosciences share count unchanged in Q2 2026.
  • Neurocrine Biosciences made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1080 holding.
  • JFS Wealth Advisors first reported a position in Neurocrine Biosciences in Q3 2019 and has held it in 21 quarters since.
  • 771 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.